Flerie Invest
23
20M
13
3
0.43
- Areas of investment
Summary
The fund has exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight OxThera, Prokarium. Among the most successful fund investment fields, there are Genetics, Health Care.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Flerie Invest, startups are often financed by SLS Venture, HealthCap, Q-Med. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Sunstone Life Science Ventures, Riyadh Valley Company. In the next rounds fund is usually obtained by Riyadh Valley Company, Korea Investment Partners, Biotechnology and Biological Sciences Research Council.
The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2016. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
Investments analytics
Analytics
- Total investments
- 23
- Lead investments
- 3
- Follow on index
- 0.43
- Investments by industry
- Biotechnology (17)
- Health Care (15)
- Pharmaceutical (14)
- Medical (8)
- Genetics (5) Show 5 more
- Investments by region
-
- United Kingdom (6)
- United States (2)
- Sweden (6)
- Israel (4)
- Netherlands (4) Show 1 more
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Avg. valuation at time of investment
- 27K
- Group Appearance index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Prokarium | 01 Jan 2012 | Biotechnology, Health Care, Genetics, Pharmaceutical | Seed | 8M | England, London, United Kingdom |
| Synerkine Pharma | 12 Oct 2023 | Biotechnology, Health Care | Early Stage Venture | 6M | Utrecht, Utrecht, Netherlands |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.